Inhibition of the N-methyl-D-aspartate receptor unmasks the antinociception of endogenous opioids in the periphery
- Authors
- Zhang, Guo Hua; Min, Sun Seek; Seol, Geun Hee; Lee, Kyu Sang; Han, Hongxiu; Kim, Yang In; Han, Hee Chul
- Issue Date
- 6월-2009
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Keywords
- NMDA; Opioid; Periphery; Interaction; Arthritic pain
- Citation
- PAIN, v.143, no.3, pp.233 - 237
- Indexed
- SCIE
SCOPUS
- Journal Title
- PAIN
- Volume
- 143
- Number
- 3
- Start Page
- 233
- End Page
- 237
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/119865
- DOI
- 10.1016/j.pain.2009.03.007
- ISSN
- 0304-3959
- Abstract
- Although N-methyl-D-aspartate (NMDA) receptor antagonists potentiate antinociceptive effects induced by various exogenous opioids at the spinal, supraspinal, or peripheral level, less is known regarding the interaction between NMDA and endogenous opioids in antinociception. We therefore assessed the effects of NMDA receptor antagonists on endogenous opioids in antinociception at the peripheral level by testing the ability of the locally administered receptor antagonists to modify pain-related behavior induced by carrageenan injection into the knee joint. The NMDA receptor antagonist AP-5 or the exogenous opioid morphine was injected intra-articularly before carrageenan injection and 5 h after carrageenan injection, respectively. We evaluated whether intra-articular injection of the opioid receptor antagonist naloxone reversed the analgesic effect of AP-5. In addition, we tested the effects of AP-5 on carrageenan-induced levels of the beta-endorphin protein in dorsal root ganglia (DRG), saphenous nerve and synovial membrane. We found that AP-5 prevented and morphine reversed carrageenan-induced pain-related behavior. Intriguingly, injection of naloxone 5 It after carrageenan injection reversed the antinociceptive effects of AP-5 pre-treatment, although naloxone alone had no effect on carrageenan-induced pain-related behavior. Western blots showed that AP-5 pre-treatment followed by carrageenan injection resulted in a higher level of P-endorphin protein in the DRG and saphenous nerve, but not in the synovial membrane, than that observed following saline control treatment. These results suggest that inhibition of the NMDA receptor unmasks antinociception induced by endogenous opioids at the peripheral level, partly through the increased protein level of the endogenous mu-opioid peptide beta-endorphin in DRG and saphenous nerve. (C) 2009 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Nursing > Department of Nursing > 1. Journal Articles
- Graduate School > Department of Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.